Phase 1, open-label, multicenter, dose escalation safety and tolerability study of oncolytic virus OVV-01 in advanced solid tumors

ABSTRACT:

SUBMITTER: Hua Y 

PROVIDER: S-EPMC12142144 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature